Skip to main content

Advertisement

Log in

Systemic Review of Published Literature on Candida Infection Following Total Hip Arthroplasty

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Candida species (Candida spp.) infection following total hip arthroplasty (THA) is a rare but potentially devastating complication. The purpose of this study was to provide an evidence-based summarization of the treatment and outcome of Candida spp. infection after THA. We conducted a systemic review of the literature and pooled analysis of Candida spp. infection after THA published between 1950 and 2014. A total of 20 articles with 37 patients were identified. Median time between THA and readmission for Candida spp. infection was 25 months (range 0.5–184 months). Thirty-two patients (87 %) underwent removal of the prosthesis for initial surgical treatment. All patients were treated with systemic antifungal medication therapy for various durations after the surgical procedure or primary therapy without surgical procedures except for one patient who was treated with only amphotericin B joint cavity irrigation after removal of the prosthesis. Relapse of the infection occurred in three patients who had retention of the original prosthesis. There were three deaths related to the Candida spp. infection following THA owing to uncontrolled Candida spp. infection and deteriorating candidemia sepsis. Of note, among 15 patients who underwent two-stage exchange arthroplasty, there was one patient (7 %) who developed complication (death) while other 14 patients had uncomplicated recovery. In conclusion, surgical debridement with removal of the original prosthesis or two-stage exchange arthroplasty with combination of adequate systemic antifungal therapy is highly recommended in the treatment of Candida spp. infection following THA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fidel PL Jr., Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999;12–1:80–96.

    Google Scholar 

  2. Cardinal E, Braunstein EM, Capello WN, Heck DA. Candida albicans infection of prosthetic joints. Orthopedics. 1996;19–3:247–51.

    Google Scholar 

  3. Evans RP, Nelson CL. Staged reimplantation of a total hip prosthesis after infection with Candida albicans. A report of two cases. J Bone Joint Surg Am. 1990;72–10:1551–3.

    Google Scholar 

  4. Wada M, Baba H, Imura S. Prosthetic knee Candida parapsilosis infection. J Arthroplasty. 1998;13–4:479–82.

    Article  Google Scholar 

  5. Simonian PT, Brause BD, Wickiewicz TL. Candida infection after total knee arthroplasty. Management without resection or amphotericin B. J Arthroplasty. 1997;12–7:825–9.

    Article  Google Scholar 

  6. Merrer J, Dupont B, Nieszkowska A, De Jonghe B, Outin H. Candida albicans prosthetic arthritis treated with fluconazole alone. J Infect. 2001;42–3:208–9.

    Article  Google Scholar 

  7. Tunkel AR, Thomas CY, Wispelwey B. Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am J Med. 1993;94–1:100–3.

    Article  Google Scholar 

  8. Artiaco S, Ferrero A, Boggio F, Colzani G. Pseudotumor of the hip due to fungal prosthetic joint infection. Case Rep Orthop. 2013;2013:502728.

    PubMed Central  PubMed  Google Scholar 

  9. Bartalesi F, Fallani S, Salomoni E, Marcucci M, Meli M, Pecile P, Cassetta MI, Latella L, Bartoloni A, Novelli A. Candida glabrata prosthetic hip infection. Am J Orthop (Belle Mead NJ). 2012;41–11:500–5.

    Google Scholar 

  10. Lidder S, Tasleem A, Masterson S, Carrington RW. Candida tropicalis: diagnostic dilemmas for an unusual prosthetic hip infection. J R Army Med Corps. 2013;159–2:123–5.

    Article  Google Scholar 

  11. Deelstra JJ, Neut D, Jutte PC. Successful treatment of Candida albicans-infected total hip prosthesis with staged procedure using an antifungal-loaded cement spacer. J Arthroplasty. 2013;28–2(374):e5–8.

    Google Scholar 

  12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327–7414:557–60.

    Article  Google Scholar 

  13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Goodman JS, Seibert DG, Reahl GE Jr, Geckler RW. Fungal infection of prosthetic joints: a report of two cases. J Rheumatol. 1983;10–3:494–5.

    Google Scholar 

  15. MacGregor RR, Schimmer BM, Steinberg ME. Results of combined amphotericin B-5-fluorocytosine therapy for prosthetic knee joint infected with Candida parapsilosis. J Rheumatol. 1979;6–4:451–5.

    Google Scholar 

  16. Anagnostakos K, Kelm J, Schmitt E, Jung J. Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplasty. 2012;27–2:293–8.

    Article  Google Scholar 

  17. Lazzarini L, Manfrin V, De Lalla F. Candidal prosthetic hip infection in a patient with previous candidal septic arthritis. J Arthroplasty. 2004;19–2:248–52.

    Article  Google Scholar 

  18. Phelan DM, Osmon DR, Keating MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis. 2002;34–7:930–8.

    Article  Google Scholar 

  19. Ramamohan N, Zeineh N, Grigoris P, Butcher I. Candida glabrata infection after total hip arthroplasty. J Infect. 2001;42–1:74–6.

    Article  Google Scholar 

  20. Darouiche RO, Hamill RJ, Musher DM, Young EJ, Harris RL. Periprosthetic candidal infections following arthroplasty. Rev Infect Dis. 1989;11–1:89–96.

    Article  Google Scholar 

  21. Lambertus M, Thordarson D, Goetz MB. Fungal prosthetic arthritis: presentation of two cases and review of the literature. Rev Infect Dis. 1988;10–5:1038–43.

    Article  Google Scholar 

  22. Hall RL, Frost RM, Vasukutty NL, Minhas H. Candida glabrata: an unusual fungal infection following a total hip replacement. BMJ Case Rep 2012;2012. doi:10.1136/bcr-2012-006491

  23. Younkin S, Evarts CM, Steigbigel RT. Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report. J Bone Joint Surg Am. 1984;66–1:142–3.

    Google Scholar 

  24. Bruce AS, Kerry RM, Norman P, Stockley I. Fluconazole-impregnated beads in the management of fungal infection of prosthetic joints. J Bone Joint Surg Br. 2001;83–2:183–4.

    Article  Google Scholar 

  25. Kelesidis T, Tsiodras S. Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option? Scand J Infect Dis. 2010;42–1:12–21.

    Article  Google Scholar 

  26. Nayeri F, Cameron R, Chryssanthou E, Johansson L, Soderstrom C. Candida glabrata prosthesis infection following pyelonephritis and septicaemia. Scand J Infect Dis. 1997;29–6:635–8.

    Article  Google Scholar 

  27. Ueng SW, Lee CY, Hu CC, Hsieh PH, Chang Y. What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin Orthop Relat Res. 2013;471–9:3002–9.

    Article  Google Scholar 

  28. Kuiper JW, van den Bekerom MP, van der Stappen J, Nolte PA, Colen S. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop. 2013;84–6:517–23.

    Article  Google Scholar 

  29. Azzam K, Parvizi J, Jungkind D, Hanssen A, Fehring T, Springer B, Bozic K, Della Valle C, Pulido L, Barrack R. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am. 2009;91(Suppl 6):142–9.

    Article  PubMed  Google Scholar 

  30. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of A. Clinical practice guidelines for the management of candidiasis update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;2009(48–5):503–35.

    Article  Google Scholar 

  31. Mukherjee PK, Chandra J. Candida biofilm resistance. Drug Resist Updat. 2004;7(4–5):301–9.

    Article  CAS  PubMed  Google Scholar 

  32. Dutronc H, Dauchy FA, Cazanave C, Rougie C, Lafarie-Castet S, Couprie B, Fabre T, Dupon M. Candida prosthetic infections: case series and literature review. Scand J Infect Dis. 2010;42(11–12):890–5.

    Article  PubMed  Google Scholar 

  33. Swieringa AJ, Goosen JH, Jansman FG, Tulp NJ. In vivo pharmacokinetics of a gentamicin-loaded collagen sponge in acute periprosthetic infection: serum values in 19 patients. Acta Orthop. 2008;79–5:637–42.

    Article  Google Scholar 

  34. Anagnostakos K, Furst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: current status. Acta Orthop. 2006;77–4:628–37.

    Article  Google Scholar 

  35. Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22–6:902–8.

    Article  Google Scholar 

  36. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89–4:871–82.

    Article  Google Scholar 

  37. Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, Jewesson PJ. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001;44–5:383–6.

    Google Scholar 

  38. Wu MH, Hsu KY. Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer. Knee Surg Sports Traumatol Arthrosc. 2011;19–2:273–6.

    Article  Google Scholar 

  39. Denes E, Fiorenza F, Saint-Marcoux F, Megherbi M, Dupon M, Weinbreck P. Voriconazole stability in cement spacers. Med Mal Infect. 2012;42–11:567–8.

    Article  Google Scholar 

  40. Austen S, van der Weegen W, Verduin CM, van der Valk M, Hoekstra HJ. Coccidioidomycosis infection of a total knee arthroplasty in a nonendemic region. J Arthroplasty. 2013;28–2(375):e13–5.

    Google Scholar 

  41. Gaston G, Ogden J. Candida glabrata periprosthetic infection: a case report and literature review. J Arthroplasty. 2004;19–7:927–30.

    Article  Google Scholar 

  42. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis. 2000;30–4:662–78.

    Article  Google Scholar 

  43. Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ. Anidulafungin Study Group. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med. 2007;356(24):2472–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

No benefits in any form have been received from a commercial party related directly or indirectly to the subject of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong Hun Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, SJ., Huh, J., Odrobina, R. et al. Systemic Review of Published Literature on Candida Infection Following Total Hip Arthroplasty. Mycopathologia 179, 173–185 (2015). https://doi.org/10.1007/s11046-014-9852-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-014-9852-3

Keywords

Navigation